What families in the UK use to manage attention-deficit/hyperactivity disorder (ADHD): a survey of resource use.

child psychiatry data collection health services research neuropathology therapeutics

Journal

BMJ paediatrics open
ISSN: 2399-9772
Titre abrégé: BMJ Paediatr Open
Pays: England
ID NLM: 101715309

Informations de publication

Date de publication:
2020
Historique:
received: 26 06 2020
revised: 13 10 2020
accepted: 15 10 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 10 12 2020
Statut: epublish

Résumé

To identify interventions being used to manage attention-deficit/hyperactivity disorder (ADHD) in the UK. A survey within the Sheffield Treatments for ADHD Research project. A convenience sample of participants in the UK who consented to join an observational cohort were asked closed questions about medication, behavioural change programmes and service use, and an open-ended question about what else they used. A broad variety of non-National Health Service, non-treatment seeking settings throughout the UK, including local authority organisations, schools, ADHD and autism spectrum condition support groups and social media. Families of children aged 5-18 with carer reported ADHD and Conners Global Index (CGI) T scores of 55+. Responses from 175 families were analysed. The mean age of the children was 10.21 (2.44), and two-thirds (n=114) had additional diagnoses. The majority used medications to manage ADHD (n=120) and had participated in a parenting class (n=130). Just over a quarter (28%, n=49) did not use ADHD medications, and used sleep medications. Just under half had consulted psychologists (n=83), and 32 had participated in other talking therapies such as psychotherapy, counselling and cognitive-behavioural therapy. A few used aids such as reward charts or fiddle toys (n=17) and participated in activities (mostly physical) (n=14). A substantial minority (78/175) had used non-mainstream treatments, the most popular being homoeopathy (n=32), nutritional interventions (n=21) and bodywork such as massage or cranial osteopathy (n=9). Families reported use of a wide variety of treatments to help with management of their children with ADHD in addition to their use of mainstream treatments.

Identifiants

pubmed: 33294627
doi: 10.1136/bmjpo-2020-000771
pii: bmjpo-2020-000771
pmc: PMC7689584
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e000771

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005648
pubmed: 17943868
Homeopathy. 2016 May;105(2):194-201
pubmed: 27211327
J Child Psychol Psychiatry. 2008 May;49(5):535-42
pubmed: 18221348
Glob Pediatr Health. 2016 Jul 01;3:2333794X15625409
pubmed: 27493983
Arch Dis Child. 2005 Feb;90 Suppl 1:i2-7
pubmed: 15665153
BMJ. 2007 Nov 10;335(7627):951
pubmed: 17991941
Neurotherapeutics. 2010 Jul;7(3):307-19
pubmed: 20643384
J Child Psychol Psychiatry. 2017 Jun;58(6):663-678
pubmed: 28295312
J Dev Behav Pediatr. 2003 Feb;24(1):4-8
pubmed: 12584479
J Pediatr Psychol. 2009 Apr;34(3):328-37
pubmed: 18676503
J Paediatr Child Health. 2005 Jan-Feb;41(1-2):23-6
pubmed: 15670219
Pediatr Neurol. 2003 Jul;29(1):53-5
pubmed: 13679122
Pilot Feasibility Stud. 2018 Mar 2;4:61
pubmed: 29511570
Pediatr Clin North Am. 1999 Oct;46(5):977-92
pubmed: 10570700
J Paediatr Child Health. 2005 Dec;41(12):625-30
pubmed: 16398864
Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885
pubmed: 26599576
J Health Psychol. 2007 Nov;12(6):851-67
pubmed: 17956965
Pediatr Clin North Am. 2007 Dec;54(6):983-1006; xii
pubmed: 18061787
J Altern Complement Med. 2005 Oct;11(5):799-806
pubmed: 16296913
BMJ. 2010 Mar 19;340:c1066
pubmed: 20304934
Acad Pediatr. 2013 Nov-Dec;13(6):540-5
pubmed: 24238680
J Autism Dev Disord. 2007 Apr;37(4):628-36
pubmed: 16977497
Altern Ther Health Med. 2002 Jan-Feb;8(1):68-70, 72-4
pubmed: 11795624
Child Care Health Dev. 2014 Nov;40(6):762-74
pubmed: 24725022
Eur Child Adolesc Psychiatry. 2016 Nov;25(11):1217-1231
pubmed: 27037707
Am J Psychiatry. 2016 Jan;173(1):34-43
pubmed: 26315982
J Altern Complement Med. 2013 Sep;19(9):746-50
pubmed: 23621389
Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I80-92
pubmed: 15322959
Cochrane Database Syst Rev. 2016 Feb 04;2:CD009996
pubmed: 26844979
J Paediatr Child Health. 1999 Oct;35(5):450-3
pubmed: 10571757
J Child Psychol Psychiatry. 2014 May;55(5):416-27
pubmed: 24552603
Eur J Pediatr. 2005 Dec;164(12):758-67
pubmed: 16047154
Child Care Health Dev. 2005 Nov;31(6):669-77
pubmed: 16207224
Psychiatr Serv. 2002 Sep;53(9):1096-102
pubmed: 12221307
Eur J Pediatr. 2019 Jul;178(7):983-993
pubmed: 31020392
Pharmacotherapy. 2003 Feb;23(2):222-30
pubmed: 12587812
Curr Psychiatry Rep. 2008 Oct;10(5):439-44
pubmed: 18803919
Arch Gen Psychiatry. 1999 Dec;56(12):1088-96
pubmed: 10591284

Auteurs

Philippa Fibert (P)

Health Hawk, High Wycombe, UK.

Clare Relton (C)

Institute of Population Health, Queen Mary University of London, London, UK.

Classifications MeSH